Price Alert

Silexion Therapeutics Ltd... (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

7.39

0.03 (0.41%)

At close: Aug 15, 2025, 3:56 PM

7.24

-2.03%

After-hours: Aug 15, 2025, 07:47 PM EDT

Silexion Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	6.15M	1.19M	1.97M	1.7M	2.78M	4.59M	58.24K	34.53K	71.5K	59.71K	202.33K	17.8K	179K	38.94K	114.59K	267.96K	346.69K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	5.58M	27.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	25K	n/a	n/a	26.85M	116.69M	115.7M	115.18M	115.02M	115.01M	115M	115M	115M
Other Long-Term Assets	52K	53K	5K	30K	30K	5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	125.1K	206.35K	325K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	92K	97K	130K	91K	93K	355.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	7.72M	2.25M	3.05M	2.31M	3.34M	4.98M	5.67M	27.48M	113.38K	103.57K	327.44K	224.16K	466.6K	407.8K	439.59K	592.96K	634.3K
Property-Plant & Equipment	534K	560K	35K	180K	216K	247K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	586K	613K	40K	210K	246K	277K	n/a	n/a	26.85M	116.69M	115.7M	115.18M	115.02M	115.01M	115.13M	115.21M	115.33M
Total Assets	8.31M	2.86M	3.09M	2.52M	3.58M	5.26M	5.67M	27.48M	26.96M	116.8M	116.03M	115.4M	115.48M	115.41M	115.57M	115.8M	115.96M
Account Payables	722K	929K	799K	281K	244K	319K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1M	229K	n/a	n/a	112K	2.49M	2.11M	1.6M	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	625K	644K	697K	596K	535K	88K	34.23K	131.68K	278.23K	86.69K	1.01M	672.16K	757.62K	348.58K	72.08K	83.88K	48.8K
Total Current Liabilities	2.4M	3.52M	3.58M	2.36M	1.94M	2.2M	2.53M	2.24M	1.88M	1.28M	1.01M	672.16K	757.62K	348.58K	72.08K	83.88K	48.8K
Long-Term Debt	2.99M	2.96M	4.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	15.06M	15.06M	15.06M	9.4K	24.34K	24.76K	29.64K	19.25K	28.8K	65.15K	160.34K	349.79K	346.94K	348.46K
Total Long-Term Liabilities	3.33M	3.33M	4.08M	15.06M	15.09M	15.12M	9.4K	24.34K	24.76K	29.64K	19.25K	28.8K	65.15K	160.34K	349.79K	346.94K	348.46K
Total Liabilities	5.72M	6.85M	7.67M	17.43M	17.03M	17.31M	2.53M	2.27M	1.91M	1.31M	1.03M	700.97K	822.77K	508.92K	421.87K	430.81K	397.26K
Total Debt	3.48M	4.49M	4.31M	116K	144K	171K	2.49M	2.11M	1.6M	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	8K	2K	1K	1K	1K	1K	5.58M	27.41M	26.85M	116.69M	115.7M	115.18M	115M	115M	115M	115M	115M
Retained Earnings	-44.99M	-43.25M	-41.58M	-29.66M	-28.18M	-26.81M	-2.45M	-2.19M	-1.79M	-1.2M	-861.47K	-1.15M	-1.2M	-951.08K	-709.31K	-485.41K	-293.61K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	2.59M	-3.99M	-4.58M	-18.26M	-16.82M	-15.48M	3.14M	25.22M	25.05M	115.49M	114.99M	114.7M	114.66M	114.91M	115.15M	115.37M	115.56M
Total Investments	n/a	n/a	n/a	n/a	n/a	25K	5.58M	27.4M	26.85M	116.69M	115.7M	115.18M	115.02M	115.01M	115M	115M	115M